Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOC2DEL: Preventive Lorazepam for ICU Delirium
NCT07428681Phase 4Not yet recruiting
- Sponsor
- University Hospital Basel
- Start
- Mar 2027
- Primary completion
- Feb 2028
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lorazepam in delirium, sponsored by University Hospital Basel. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
lorazepam
03
Conditions
delirium
Beyond the preview
Go deeper on NCT07428681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07428681.